FDA Halts 3 Merck Keytruda Studies After Deaths
Merck & Co. said Wednesday the U.S. Food and Drug Administration has halted or partly halted three clinical studies testing its Keytruda drug as a blood cancer treatment, after a greater...To view the full article, register now.
Already a subscriber? Click here to view full article